熊去氧胆酸在原发性胆汁性肝硬化临床治疗中的进展

被引：16

作者：

樊雪强

王彩生

刘金涛

萨茹拉

孙婧

包双宝

机构：

[1] 内蒙古呼和浩特市第二医院

来源：

中国医药导报 | 2016年 / 13卷 / 24期

关键词：

熊去氧胆酸; 原发性胆汁性肝硬化; 替代治疗;

D O I：

暂无

中图分类号：

R575.22 [];

学科分类号：

摘要：

本文回顾了熊去氧胆酸治疗原发性胆汁性肝硬化在国内外的研究现状,简述了熊去氧胆酸应答不佳的原因、发生机制及临床表现,介绍了国内外学者对于熊去氧胆酸应答不佳的主要处理方法。提出了随着熊去氧胆酸在原发性胆汁性肝硬化中的广泛应用及越来越多应答不佳患者的出现,替代治疗或联合治疗成为未来发展趋势及研究方向。

引用

页码：58 / 61

页数：4

共 27 条

[1]

Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid [J].

Hirschfield, Gideon M. ;

Mason, Andrew ;

Luketic, Velimir ;

Lindor, Keith ;

Gordon, Stuart C. ;

Mayo, Marlyn ;

Kowdley, Kris V. ;

Vincent, Catherine ;

Bodhenheimer, Henry C., Jr. ;

Pares, Albert ;

Trauner, Michael ;

Marschall, Hanns-Ulrich ;

Adorini, Luciano ;

Sciacca, Cathi ;

Beecher-Jones, Tessa ;

Castelloe, Erin ;

Boehm, Olaf ;

Shapiro, David .

GASTROENTEROLOGY, 2015, 148 (04) :751-U347

[2]

Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid [J].

Lens, Sabela ;

Leoz, Maria ;

Nazal, Leyla ;

Bruguera, Miguel ;

Pares, Albert .

LIVER INTERNATIONAL, 2014, 34 (02) :197-203

[3]

Chronic nicotine exposure stimulates biliary growth and fibrosis in normal rats [J].

Jensen, Kendal ;

Afroze, Syeda ;

Ueno, Yoshiyuki ;

Rahal, Kinan ;

Frenzel, Amber ;

Sterling, Melanie ;

Guerrier, Micheleine ;

Nizamutdinov, Damir ;

Dostal, David E. ;

Meng, Fanyin ;

Glaser, Shannon S. .

DIGESTIVE AND LIVER DISEASE, 2013, 45 (09) :754-761

[4]

Early Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis of Primary Biliary Cirrhosis: Results of a 14-Year Cohort Study [J].

Zhang, Li-Na ;

Shi, Tian-Yan ;

Shi, Xu-Hua ;

Wang, Li ;

Yang, Yun-Jiao ;

Liu, Bin ;

Gao, Li-Xia ;

Shuai, Zong-Wen ;

Kong, Fang ;

Chen, Hua ;

Han, Wei ;

Han, Shao-Mei ;

Fei, Yun-Yun ;

Cui, Quan-Cai ;

Wang, Qian ;

Shen, Min ;

Xu, Dong ;

Zheng, Wen-Jie ;

Li, Yong-Zhe ;

Zhang, Wen ;

Zhang, Xuan ;

Zhang, Feng-Chun .

HEPATOLOGY, 2013, 58 (01) :264-272

[5]

Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid.[J].Marco Carbone;George Mells;Greta Pells;Muhammad F. Dawas;Julia L. Newton;Michael Heneghan;James Neuberger;Darren Day;Samantha J. Ducker;Richard Sandford;Graeme Alexander;David E.J. Jones.Gastroenterology.2012,

[6]

Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review [J].

Boonstra, Kirsten ;

Beuers, Ulrich ;

Ponsioen, Cyriel Y. .

JOURNAL OF HEPATOLOGY, 2012, 56 (05) :1181-1188

[7]

Primary biliary cirrhosis [J].

Selmi, Carlo ;

Bowlus, Christopher L. ;

Gershwin, M. Eric ;

Coppel, Ross L. .

LANCET, 2011, 377 (9777) :1600-1609

[8]

Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis.[J].Christophe Corpechot;Farid Gaouar;Yves Chrétien;Catherine Johanet;Olivier Chazouillères;Raoul Poupon.Journal of Hepatology.2011, 1

[9]

28 AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID AS MONOTHERAPY IN PBC.[J].K.V. Kowdley;D. Jones;V. Luketic;R. Chapman;A. Burroughs;G. Hirschfield;R. Poupon;C. Schramm;C. Vincent;C. Rust;A. Pares;A. Mason;C. Sciacca;T. Beecher-Jones;O. Bohm;E. Castelloe;M. Pruzanski;D. Shapiro.Journal of Hepatology.2011,

[10]

Bezafibrate Treatment of Primary Biliary Cirrhosis Following Incomplete Response to Ursodeoxycholic Acid [J].

Hazzan, Rawi ;

Tur-Kaspa, Ran .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (05) :371-373

← 1 2 3 →